Employee Elected Director to step down from the board of Zealand Pharma A/S
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen,...
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen,...
SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani Therapeutics” or “Rani”), a clinical...
MINNEAPOLIS, MN, Aug. 13, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (“PetVivo” or the “Company”), an emerging...
NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
RENO, NV, Aug. 13, 2021 (GLOBE NEWSWIRE) -- XcelPlus International Inc. (OTC PINK: XLPID) announced today that it intends to actively...
TUCSON, Ariz., Aug. 13, 2021 (GLOBE NEWSWIRE) -- The voluntary COVID-19 vaccination program has failed to achieve 100 percent compliance,...
Toronto, Ontario--(Newsfile Corp. - August 13, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is...
EASTON, PA / ACCESSWIRE / August 13, 2021 / Paragon Technologies, Inc. (OTC PINK:PGNT), a holding company, announced its results...
100+ Years of Cannabis ExperienceDENVER, CO and CALGARY, AB / ACCESSWIRE / August 13, 2021 / Unified Global Corp of...
Company reports net income of $2.8 million with forgiveness of PPP loanPLAINVIEW, NY / ACCESSWIRE / August 13, 2021 /...
Second quarter 2021 Mytesi® net and gross sales were approximately $0.4 million and approximately $4.9 millionCompany transitioning to primarily selling...
Combination of Synergistic Organizations Results in Broad CDMO Service with Capabilities Spanning from Pre-IND Development to Commercial Manufacturing and Packaging...
Reported positive, statistically significant top-line efficacy and safety data from pivotal Phase 3 NORSE TWO trial of ONS-5010 / LYTENAVA™...
- Enrolled the First Patient in the Phase 2/3 Pivotal Trial of AL102 for the Treatment of Desmoid Tumors -...
TRG-100 is now being evaluated in broad range of bladder disordersRAANANA, Israel, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trigone Pharma...
Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586CRANBURY, N.J., Aug. 13, 2021 (GLOBE NEWSWIRE) -- PMV...
Consolidated Net Revenue of $21.7 Million up 117% vs. Second Quarter of 2020Consolidated Net Product Revenue of $10.7 Million up...
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
SAN CARLOS, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for...
AUSTIN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative,...